1.
A Mele, G Sparaventi, B Guiducci, G Nicolini, F d’Adamo, G Leopardi, C Delfini, P Piccaluga, G Visani. Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. haematol [Internet]. 2004Jun.1 [cited 2024Jul.18];89(6_Suppl):ECR18-ECR18. Available from: https://haematologica.org/article/view/3135